SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-07-001869
Filing Date
2007-05-18
Accepted
2007-05-18 11:34:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 UNITED THERAPEUTICS CORPORATION sc13g.txt SC 13G 36335
  Complete submission text file 0000902664-07-001869.txt   38143
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Subject) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-57843 | Film No.: 07863538
SIC: 2834 Pharmaceutical Preparations

Mailing Address 666 FIFTH AVENUE, 34TH FLOOR NEW YORK NY 10103
Business Address 212-484-5030
Catenacci Gerald (Filed by) CIK: 0001296103 (see all company filings)

Type: SC 13G